Preview Only, Purchase Required For Full Program Access.
Effective Date: September 1, 2019
Expiration Date: August 31, 2021
Format: Self Instructional - Audio Visual Voice-Over with Slides
Maximum Credits: 1.0 AMA PRA Category 1 CME Credit™, 1.0 Nursing Contact Hour (1.0 Pharmacologic Hour), 1.0 Hour Pharmacy CE
Estimated Completion Time:1 hour
In this presentation, Nathan S. Bryan will provide an overview of the atmospheric and human nitrogen cycles and nitric oxide production pathways in humans. He will review evidence based nitric oxide research specific to vascular function and structure. In addition to nitric oxide production, he will review the importance of nitrate and how much is recommended daily for health benefits. Dr. Bryan will also discuss nitric oxide therapeutic interventional outcome data and how to control and regulate nitric oxide production.
This program is intended for Primary Care Physicians, Physician Assistants, Nurse Practitioners, Nurses, Pharmacists and Other Healthcare Professionals.
Upon completion of this CME/CE activity the healthcare provider will be able to:
Nathan S. Bryan, Ph.D.
Baylor College of Medicine
Dr. Bryan earned his undergraduate Bachelor of Science degree in Biochemistry from the University of Texas at Austin and his doctoral degree from Louisiana State University School of Medicine in Shreveport where he was the recipient of the Dean’s Award for Excellence in Research. He pursued his post-doctoral training as a Kirschstein Fellow at Boston University School of Medicine in the Whitaker Cardiovascular Institute. After a two year post-doctoral fellowship, in 2006 Dr. Bryan was recruited to join faculty at the University of Texas Health Science Center at Houston by Ferid Murad, M.D., Ph.D., 1998 Nobel Laureate in Medicine or Physiology. During his tenure as faculty and independent investigator at UT, his research focused on drug discovery through screening natural product libraries for active compounds. His nine years at UT led to several discoveries which have resulted in over a dozen issued US and international patents and many more pending worldwide.
Specifically, Dr. Bryan was the first to describe nitrite and nitrate as indispensable nutrients required for optimal cardiovascular health. He was the first to demonstrate and discover an endocrine function of nitric oxide via the formation of S-nitrosoglutathione and inorganic nitrite. Through the drug discovery program in natural product chemistry, Dr. Bryan discovered unique compositions of matter than can be used to safely and effectively generate and restore nitric oxide in humans. This technology is now validated in six published clinical trials.
He is also a successful entrepreneur who has commercialized his nitric oxide technology through the formation of Human, to the Power of N, Inc (formerly Neogenis Labs) where he is a Founder and inventor. Dr. Bryan has been involved in nitric oxide research for the past 18 years and has made many seminal discoveries in the field. These discoveries and findings have transformed the development of safe and effective functional bioactive natural products in the treatment and prevention of human disease and may provide the basis for new preventive or therapeutic strategies in many chronic diseases. Dr. Bryan has published a number of highly cited papers and authored or edited 5 books. He is an international leader in molecular medicine and nitric oxide biochemistry.
It is the policy of the Foundation for Care Management (FCM) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. FCM requires everyone in a position to control the content of this activity to disclose any relevant financial conflicts of interest they may have as related to the content of this activity and having occurred within the last 12 months. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned. All identified conflicts of interest are thoroughly vetted by FCM for fair balance, scientific objectivity of studies mentioned in the material or used as the basis for content, and appropriateness of patient care.
"A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients."
Nathan S. Bryan, Ph.D. Baylor College of Medicine-Houston, Texas. Dr.Bryan is the founder and shareholder of Human N, Shareholder and advisor for SAJE Pharma and receives royalties on patents from University of Texas Health Sciences Center at Houston.
Nathan S. Bryan, Ph.D. Content Expert, and Beth York, FNP-C, Lead Nurse Planner, have no financial interest in any of the products or manufacturers mentioned.
Accreditation Statement: The Foundation for Care Management (FCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for Physicians.
Designation Statement: FCM designates this educational activity for a maximum of 1.0 AMA PRA Category 1 credits™. Physicians should only claim credit commensurate with the extent of the participation in the activity.
The Foundation for Care Management is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Program # 0347-0000-19-012-H01-P. All objectives are appropriate for pharmacists
* This CE activity is knowledge-based.
Accreditation Statement: The Foundation for Care Management is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. 1 Nursing contact hour(s).
To receive CME/CE credits, participants must review the program materials in their entirety and complete the online post examination and evaluation with a score of 70% or better. A statement of credit will be available for printing upon successful completion.
If you have questions about this CE activity, please contact FCM at debbiedunn@FCMcme.org.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.